Related Experiment Video
Updated: Aug 24, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
[Liver cirrosis and complication risk management]
I G Bakulin1, I A Oganezova1, M I Skalinskaya1
1Mechnikov North-Western State Medical University.
Liver cirrhosis (LC) is a major cause of death, with gut microbiota dysbiosis and increased intestinal permeability playing key roles in its progression and complications. Targeting the gut-liver axis offers new strategies for managing LC risks.
Area of Science:
- Gastroenterology and Hepatology
- Microbiology
- Pathophysiology
Context:
- Liver cirrhosis (LC) is a leading cause of digestive system mortality and complications.
- Effective prevention strategies for LC progression and complications are urgently needed.
- The gut-liver axis is increasingly recognized for its role in LC pathogenesis.
Purpose:
- To provide updated information on the role of intestinal microbiota, endotoxemia, and intestinal permeability in liver cirrhosis.
- To present findings from meta-analyses on dysbiosis and LC prognosis.
- To highlight the significance of the gut-liver axis in managing LC complications.
Summary:
- Dysbiosis, endotoxemia, and increased intestinal permeability are critical factors in liver cirrhosis pathophysiology.
- Meta-analyses confirm the negative impact of gut dysbiosis on LC prognosis.
- Interventions targeting gut microbiota show potential for correcting dysbiotic disorders.
- The gut-liver axis is a central pathway in the development of major LC complications.
Impact:
- Understanding the gut-liver axis provides novel insights into managing liver cirrhosis.
- Modulating intestinal microbiota may offer therapeutic avenues for preventing LC complications.
- This knowledge advances the development of targeted interventions for liver disease patients.
More Related Videos
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Esophageal Varices-I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

